Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
Aligos Therapeutics (ALGS) Financial Statements
51 Followers
Aligos Therapeutics Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 140.00K | - | $ 4.11M | $ 3.69M | $ 2.57M |
| Gross Profit | $ 140.00K | - | - | - | - |
| EBIT | $ -22.92M | $ -21.91M | $ -18.95M | $ -20.39M | $ -35.56M |
| EBITDA | $ -22.29M | $ -21.10M | $ -18.04M | $ -19.50M | $ -34.57M |
| Net Income Common Stockholders | $ -22.95M | $ -21.94M | $ -18.62M | $ -19.92M | $ -35.62M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 103.91M | $ 125.93M | $ 142.30M | $ 159.34M | $ 183.22M |
| Total Assets | $ 121.74M | $ 141.86M | $ 164.07M | $ 182.52M | $ 210.47M |
| Total Debt | $ 11.96M | $ 12.57M | $ 13.03M | $ 13.44M | $ 14.38M |
| Net Debt | $ -91.95M | $ -113.35M | $ -129.27M | $ -145.91M | $ -168.84M |
| Total Liabilities | $ 36.99M | $ 146.71M | $ 42.06M | $ 45.54M | $ 57.58M |
| Stockholders Equity | $ 84.75M | $ 103.92M | $ 122.01M | $ 136.98M | $ 152.89M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -22.35M | $ -16.89M | $ -17.14M | $ -25.37M | $ -20.95M |
| Operating Cash Flow | $ -22.34M | $ -16.80M | $ -17.14M | $ -25.04M | $ -20.43M |
| Investing Cash Flow | $ 19.99M | $ 11.60M | $ 32.48M | $ -9.98M | $ -60.40M |
| Financing Cash Flow | $ -1.00K | $ 101.00K | $ -19.00K | $ 83.00K | $ -21.00K |